EMEA-001094-PIP01-10-M04

Key facts

Invented name
Aubagio
Active substance
Teriflunomide
Therapeutic area
Neurology
Decision number
P/0165/2017
PIP number
EMEA-001094-PIP01-10-M04
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
Genzyme Europe B.V. / Sanofi-Aventis groupe
The Netherlands
Tel. +31 356991299
E-mail: eumedinfo@genzyme.com
 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating